Advanced systemic mastocytosis with strong expression of signaling lymphocyte activation marker family member 7 (SLAMF7) responsive to therapy with elotuzumab and lenalidomide

(2020) [Journal Article]

Leukemia and lymphoma
Volume: 61
Issue: 2
Page(s): 485-487


Selected Authors

Elmaagacli, Ahmet H.
Jehn, Christian
Shikova, Yana
Huber, Michael
Salwender, Hans

Other Authors

Dahmash, Farouk
Singh, Anju
Niggemann, Cornelius
Vierbuchen, Mathias